Recalls & Warnings October 06, 2005 Deceptive Marketing of Supreme Greens" -- Settlement with FTC On October 6, 2005, the Federal Trade Commission (FTC) announced that three individuals and two companies have settled FTC charges over their roles in the deceptive marketing of Supreme Greens, an herbal supplement
Because pigmentation reflects downstream cellular changes rather than an immediate on/off response, observed effects are typically gradual and depend on individual biology, baseline skin type, UV exposure, and melanocyte activity
The lawsuit alleges that manufacturers Novo Nordisk and Eli Lilly failed to properly warn patients and healthcare providers about the risks associated with using Ozempic and other GLP-1 drugs
Sugary and ultra-processed foods including fizzy drinks, sweets, cakes, and highly refined snacks offer little nutritional value and can cause rapid fluctuations in blood glucose
Those with a history of pancreatitis, medullary thyroid cancer, or severe gastrointestinal disorders should have an open discussion with their healthcare provider